{
    "root": "a74390de-64e9-482d-8630-d1a2452324fe",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "Potassium Chloride"
    },
    "value": "20250329",
    "ingredients": [
        {
            "name": "POTASSIUM CHLORIDE",
            "code": "660YQ98I10"
        },
        {
            "name": "ETHYLCELLULOSE (10 MPA.S)",
            "code": "3DYK7UYZ62"
        },
        {
            "name": "ETHYLCELLULOSE (100 MPA.S)",
            "code": "47MLB0F1MV"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "HYDROGENATED COTTONSEED OIL",
            "code": "Z82Y2C65EA"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FD&C YELLOW NO. 5",
            "code": "I753WB2F1M"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        }
    ],
    "indications": "Potassium Chloride Extended-release Tablets, USP is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.",
    "contraindications": "Monitor serum potassium and adjust      dosages accordingly (2.1) If serum potassium is less than 2.5      mEq/L, use intravenous potassium instead of oral supplementation (2.1) Take with meals and with a glass of      water or other liquid. Swallow tablets whole without crushing, chewing or      sucking. (2.1) Treatment of hypokalemia: Doses range from 40-100 mEq/day in divided doses. Limit doses      to 40 mEq per dose. (2.2) Prevention of hypokalemia: Typical      dose is 20 mEq per day. (2.2)",
    "warningsAndPrecautions": "Potassium Chloride Extended Release Tablets, USP 8 mEq [600mg] are blue colored, circular biconvex film coated tablets plain on one side and debossed \"P8\" on another side. \n                  600 mg potassium chloride (equivalent to 8 mEq) are available in bottles of 100 (NDC 64380-860-06), bottles of 500 (NDC 64380-860-07), bottles of 1000 (NDC 64380-860-08). \n                  Potassium Chloride Extended Release Tablets, USP 10 mEq [750mg] are yellow colored, circular biconvex film coated tablets plain on one side and debossed \"P10\" on another side. \n                  750 mg potassium chloride (equivalent to 10 mEq) are available in bottles of 100 (NDC 64380-861-06), bottles of 500 (NDC 64380-861-07), bottles of 1000 (NDC 64380-861-08).\n                  Store at 25ºC (77ºF) [See USP Controlled Room Temperature]. Protect from light and moisture. \n                  Dispense in a tight container as defined in the USP with a child resistant closure.",
    "adverseReactions": "Potassium chloride is contraindicated in patients on triamterene and amiloride."
}